Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$609,310
+$142,067 QoQ
Shares Held
508
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#3,584
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arlington Financial Advisors, LLC holds $15,667,328 across 4 Drug Manufacturers - General names. LLY ranks #3 (3.9% of the industry book) .
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $609,310 | 508 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $467,243 | 508 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $545,937 | 508 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $387,604 | 508 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $396,001 | 508 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $536,841 | 650 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $392,176 | 508 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $383,612 | 433 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $392,029 | 433 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $336,856 | 433 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $213,348 | 366 | Shares | Sole | 2024-01-09 | |
| No filing history on record for this holder in this stock. | ||||||